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Mild ischemia predisposes the S3 segment to gentamicin toxicity. The
purpose of these studies was to determine if a functionally insignificant
ischemic insult, occurring prior to gentamicin administration, enhanced
gentamicin nephrotoxicity. Bilateral renal pedical clamp studies dem-
onstrated that 15 minutes of ischemia did not increase the plasma
creatinine yet markedly enhanced gentamicin nephrotoxicity. Further
studies, in uninephrectomized rats, demonstrated that following fifteen
minutes of renal ischemia and four hours of reperfusion inulin clear-
ance, FENa* and cellular morphology were normal. This model, there-
fore, was used in all subsequent studies. While the plasma creatinine
concentrations were normal 24 hours following 15 minutes of ischemia
and only slightly increased following gentamicin administration (100
mg/kg, i.p.) gentamicin administered four hours following 15 minutes of
renal ischemia resulted in significantly increased 24-hour plasma creat-
mine values. Light microscopic quantitation of tissue injury, performed
24 hours following experimental manipulation, was notable for S3
segment damage in the ischemia plus gentamicin group. This was not
observed in either the ischemia group or the sham operated gentamicin
group. Cortical gentamicin levels were elevated in the ischemia plus
gentamicin group, despite similar plasma gentamicin half-lives. How-
ever, the elevation in cortical gentamicin levels was dissociated from
the enhanced nephrotoxicity seen following mild ischemic injury.
Taken together these data indicate that mild renal ischemia, occurring
prior to gentamicin administration, greatly enhanced gentamicin neph-
rotoxicity with the greatest damage occurring to S3 cells.
Aminoglycosides remain the most commonly used antibiotics
in the treatment of serious gram negative infections. The high
incidence of nephrotoxicity associated with these drugs makes
understanding the pathophysiology of aminoglycoside renal
injury critical. Clinically a number of factors including pre-
existing renal disease, drug dose and duration, and hypokalemia
appear to predispose patients to aminoglycoside nephrotoxicity
[1]. In experimental animal models these factors in addition to
endotoxemia [2] and hypomagnesemia can accelerate and en-
hance aminoglycoside nephrotoxicity [3]. The mechanism(s)
whereby these conditions enhance gentamicin toxicity, how-
ever, in large part remains unclear. Several studies suggest that
increased renal cortical gentamicin levels account for the in-
creased toxicity [4—6] while others do not support this hypoth-
esis [2, 7, 8]. It has also been shown that pretreatment [91 and
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concurrent treatment [10] with gentamicin greatly enhances the
acute renal failure (ARF) from an ischemic insult.
Clinically we have observed that a number of patients de-
velop acute renal failure after only one or two doses of an
aminoglycoside antibiotic. While the ARF in these patients is
often termed multifactorial, due to the critical nature of their
illness, we questioned whether mild, often clinically unrecog-
nized renal ischemia might predispose these patients to acute
aminoglycoside nephrotoxicity.
Our purpose, therefore, was to investigate whether a mild,
functionally insignificant ischemic renal insult predisposes to or
enhances gentamicin nephrotoxicity and, if so, to determine the
cellular site and mechanism.
Methods
Animal protocol
Male Sprague-Dawley rats (200 to 300 g) were allowed free
access to standard chow and water. All animals were matched
for weight prior to surgery which was performed under pento-
barbital (60 mg/kg body wt) anesthesia. At the completion of
surgery 1 ml of warmed 0.9% saline was instilled intraperitoneal
prior to closure. In the initial bilateral renal clamp studies
ischemia was produced by applying two Schwartz vascular
clamps across both renal pedicles after decapsulating the kid-
neys and carefully cleaning the artery and vein and separating
them from the ureter as we have previously described [11, 12].
Sham surgery consisted of decapsulating the kidney and clean-
ing and separating the artery and vein from the ureter. Blood
was sampled by tail artery puncture with a 25 g heparinized
needle while the animal was under methoxyflurane anesthesia
or following decapitation while under pentobarbital anesthesia.
This model was used to evaluate the effect of varying ischemia
time on renal function and the added effect of gentamicin given
on a daily basis. The evaluation of morphology, tissue genta-
micin levels and clearance studies were performed in a right
uninephrectomy model. The right nephrectomy was performed
at the time the abdominal cavity was opened for the placement
of the vascular clamp or sham surgery. In these studies several
1 mm sections of the left kidney were immersed in 10% formalin
for light microscopic morphology. When appropriate, the re-
mainder of the cortex from the left kidney was removed,
weighed, tightly wrapped in paraflim and stored at —20°C for
measurement of tissue gentamicin levels. Plasma was separated
by centrifugation and stored at —20°C until analyzed.
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Inulin clearances and gentamicin half-lives were performed
on right uninephrectomized pentobarbital anesthetized rats four
hours after the left kidney underwent sham surgery or 15
minutes of renal ischeniia. A constant inulin infusion via the
right internal jugular vein was used to maintain a serum level
between 50 and 100 mg/dl. After a one hour equilibration period
two 30-"'inute urine collections were obtained via a bladder
catheter, bounded by blood samples. Inulin clearances were
calculated using the standard formula. Gentamicin half-lives
were determined from plasma gentamicin levels obtained by
repeated blood sampling following the intravenous injection of
25 mg/kg of gentamicin via the jugular vein. Blood was sampled
from the femoral artery at 10, 20, 30, 40, 50, and 60 minutes.
Morphology
Coronal sections from the left kidney were immersion fixed in
10% buffered formalin and processed by routine methods to
paraffin embedded 6 m thick sections stained with hematoxy-
lin-eosin. Each section was then examined by a renal patholo-
gist (PFS), without prior knowledge of the experimental condi-
tions, for the presence of overt tubular necrosis. Degenerative
changes short of coagulative necrosis were disregarded. Prelim-
inary evaluation showed that necrosis was confined in all
instances to the proximal tubules and was generally limited in
extent. Necrosis was scored separately in the cortical laby-
rinths (where proximal convoluted tubules (Si, S2) reside and
in the subcortex and medullary rays (where pars recta tubules
(S3) reside by the following system:
0 = No necrotic tubules identified.
I + = Isolated single tubules with necrosis scattered
throughout the sections.2+ = Groups of tubules with necrosis scattered throughout
the section.3+ = Diffuse tubule necrosis in the region under study.
Analytical
Sodium (Na) was measured by IL Flame Photometer Model
343 (Lexington, Massachusetts, USA). Creatinine was mea-
sured on a Beckman Creatinine Analyzer II. Inulin was deter-
mined by autoanalyzer method as previously described [13].
Plasma gentamicin concentration was determined by a standard
radioimmunoassay (TDx Gentamicin). Tissue gentamicin levels
were determined by a modification of the technique of Giulliano
et al [14]. Briefly, a 100 to 200 mg renal cortical slice removed,
from the left kidney after the animal was bled by decapitation
was immediately weighed, tightly wrapped in Parafilm, and
stored frozen at —20°C. At The time of analysis, the tissue was
thawed and homogenized with a Potter-Elvehjem (borosilicate
glass homogenizer and teflon piston) in S ml of 100 mM
phosphate buffer (pH 7.4) for five strokes. The homogenate was
centrifuged in a polypropylene tube (tube A) at 1,200 g for five
minutes. The supernate was decanted into a second polypro-
pylene tube (tube B). The pellet was resuspended with a 22 G
needle in 5 ml of buffer and the homogenization step repeated.
This homogenate was combined with the supernate in tube B.
Five milliliters of buffer and 1 ml of 50% trichloroacetic acid
(TCA) were then added to tube A and transferred to the
Potter-Elvehjem with the 22 G needle used previously and
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Fig. 1. Effect of the duration of rena! ischemia on plasma creatinine.
Rats underwent sham surgery, 15 or 25 minutes of bilateral renal pedicle
clamp ischemia. Serum creatinine concentration was quantitated 24
hours later. The number of individual observations (N) is shown for
each group. Data represent the mean SD.
taken through 15 strokes. This fluid was added to tube B. This
final step was repeated with 5 ml of buffer and 1 ml of 50% TCA
and the fluid again added to tube B which was then agitated and
allowed to stand for 15 minutes prior to centrifugation at 1,200
g for 20 minutes. The pellet was discarded and the supernate
was taken to pH 7.4 with 10% NaOH. The final volume was
measured and an aliquot was removed for determination of
gentamicin level by standard radioimmunoassay. This tech-
nique recovered 98 0.5% of the gentamicin added to homog-
enized control samples.
Statistics
Differences between groups were evaluated by one way
ANOVA using an IBM statistical package (ABSTAT, version
423, Anderson-Bell, Parker, Colorado, USA). Significance was
defined as a P value of < 0.05 and reported as P < 0.05 or P <
0.01. Values in the text represent the mean 1 SD.
Results
Initial studies were designed to establish a model of function-
ally insignificant renal ischemia. Rats were subjected to sham
surgery, a 15-minute bilateral pedicle clamp, or a 25-minute
bilateral clamp. Blood was sampled at 24 hour intervals until the
plasma creatinine returned to baseline. The peak in plasma
creatinine, as a result of ischemia, occurred at 24 hours. Figure
1 shows that the 24-hour plasma creatinine was not elevated by
sham surgery (0.5 0.1) or the 15-minute bilateral pedicle
clamp model (0.5 0.1) over baseline (0.5 0.1 mgldl).
However, 25 minutes of ischemia resulted in significant eleva-
tion of the plasma creatinine at 24 hours (1.2 0.2; P < 0.01)
when compared to controls.
To determine whether the functionally insignificant ischemic
insult resulting from 15 minutes of renal pedicle clamping
altered gentamicin induced nephrotoxicity, sham operated and
rats subjected to 15 minutes of renal ischemia were allowed four
hours of recovery prior to receiving the first dose of intraperi-
toneal (i.p.) gentamicin (100 mg/kg). This was followed by daily
doses of gentamicin (100mg/kg, i.p.) given as a single injection.
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Fig. 2. Effect ofpriorfunctionaliv insignflcant ischemia on gentainicin
induced nephrotoxicitv. Rats that underwent bilateral pedicle clamp
(A----A 15 mm ischemia) or sham surgery (• I) were given genta-
micin (100 mg/kg, i.p.) 4 hours following surgery and then at 24 hour
intervals. Data points represent the mean 5D (N = 6). Where error
bars are not evident, the standard deviation was smaller than the
symbol used to indicate the mean. When compared to the sham
operated group * P < 0.05 and ** P < 0.01.
Four hours of recovery were allowed prior to gentamicin
administration since previous work from ours and other labo-
ratories had shown that morphologic recovery following 15
minutes of renal ischemia was rapid and complete within this
time frame [15—17]. Blood was sampled on days 1, 3 and 6.
Figure 2 shows that the ischemia plus gentamicin group (IS+G)
had an earlier and greater rise in their plasma creatinine
compared with sham operated rats given the same dose of
gentamicin (Sham + G). Plasma creatinines were significantly
different after only one dose of gentamicin (IS+G: 1.0 0.3 vs.
Sham+G: 0.6 0.1, P < 0.05) and on day 6 extremely large
differences were noted (IS+G: 6.0 2.5 vs. Sham+G: 2.0
1.2, P < 0.01). The differences in serum creatinine on days 1
and 3 were not due to changes in body weight as the Sham+G
and IS+G groups weighed 90 2% and 88 2% of their initial
weights, respectively. By day 8, mortality was 83% in the IS+G
group compared with 0% in the Sham+G group.
A single dose of G also resulted in a significant increase in
plasma creatinine in a 25-minute ischemia model. Twenty-five
minutes of renal ischemia followed four hours later by one dose
of gentamicin (100 mg/kg, i.p.) resulted in a 24-hour plasma
creatinine of 3.3 1.5 (N 6), a value significantly greater than
produced by 25 minutes of ischemia alone 1.4 0.8 mg/dl (N =
6, P < 0.05).
We next sought to determine the mechanism for the enhanced
gentamicin toxicity following functionally insignificant ische-
mia. To accomplish this goal the right uninephrectomy model
was used to eliminate variability in the ischemic injury between
kidneys and to insure that all kidneys evaluated for tissue
gentamicin levels and morphology were exposed to the same
dose of gentamicin. With this model the 24-hour plasma creat-
mine in uninephrectomized sham operated rats was 0.7 0.1
mg/dl, N = 5 (Table 1). Fifteen minutes of ischemia did not
increase the 24-hour plasma creatinine (0.7 0.1; N = 5) over
control values. Furthermore, the glomerular filtration rate
Table 1. Plasma creatinine and cortical gentamicin level 24 hours
post-treatment
24-Hour 24-Hour cortical
plasma G level
creatinine xg/g wet tissue
Treatment N mg/dl weight
Sham surgery 5 0.68 008d
15 Minutes 5 0.68 0.08"
ischemia
Sham + G 8 0.83 0.13 1082.0 206.4"
100 mg/kg
Is + G 8 1.09 0.20" 1460.8 209.7
100 mg/kg
Sham + G 5 0.86 0.09 1442.8 148.4
175 ,ng/kg
All rats underwent a right uninephrectomy in addition to the treat-
ment listed. Data represents mean 1 SD. N refers to the number of
animals studied.
a P < 0.05 vs. Sham surgery
"P < 0.01 vs. Sham surgery
' P < 0.05 vs. Is + G (100 mg/kg)
d P < 0.01 vs. Is + G (100 mg/kg)
(GFR), as measured by inulin clearances, performed four hours
following 15 minutes of ischemia and right uninephrectomy was
unchanged from right uninephrectomized controls (Is: 0.47
0.03, Control: 0.46 0.05 mi/mm, N = 5). Tubular sodium
handling, as assessed by the fractional excretion of sodium, was
also not different between these groups when studied four hours
following the ischemic insult; (Is: 2.4 1.2, Control: 2.1
0.5%, N = 5). Sham+G (100 mg/kg) treated rats had a 24 hours
creatinine of 0.8 0.1, a valve slightly but significantly greater
than sham treated control animals (P < 0.05). However, IS+G
(100 mg/kg) treated rats had a marked increase in their 24-hour
plasma creatinine to 1.1 0.2 mg/dl (P < 0.1 vs. Sham+G or
ischemia alone).
To determine the site of nephron injury in this model, light
microscopic quantitation of tissue injury was performed on
tissue obtained 24 hours following: sham surgery, 15 minutes of
renal ischemia, 15 minutes of renal ischemia with four hours
recovery plus gentamicin (100 mg/kg), or sham surgery with
four hours recovery plus gentamicin (100 or 175 mg/kg, Table
2). Following fifteen minutes of renal ischemia the twenty-four
hour cellular morphology was normal. When gentamicin, either
100 or 175 mg/kg was administered to sham operated rats
minimal tubular damage was seen in only one of thirteen S l/S2
segments and two of thirteen S3 segments. However, the
combination of 15 minutes of ischemia, with four hours of
recovery, followed by gentamicin (100 mg/kg) resulted in mark-
edly increased tubular injury. The damage was most notable in
the S3 segment of the proximal tubule, where seven out of eight
kidneys showed evidence of tubular injury compared to only
two of thirteen Sham+G (100 or 175 mg/kg) treated kidneys (P
<0.01).
We next evaluated cortical gentamicin levels in the unine-
phrectomized model to determine if previous mild ischemia,
which did not affect GFR, altered the intracellular gentamicin
concentration. Cortical gentamicin levels (Table 1) were signif-
icantly elevated in the IS+G (100 mg/kg) group compared to the
Sham+G (100 mg/kg) group, (1461 210 vs. 1082 206 g/g
wet weight; P < 0.01, N = 8). This higher cortical gentamicin
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Table 2. Morphology at 24 hours post-treatment
All rats underwent a right uninephrectomy in addition to the treatment listed.
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••• Fig. 3. Relationship between plasma
creatinine and renal cortical gentamicin
levels. Plasma creatinine and renal cortical
1.0 1.5 gentamicin levels were determined 24 hours
______________
after the experimental manipulation. Symbols
1.5 used to represent individual groups are: (•)
sham + G (100 mg/kg); (•) ischemia + G (100
mg/kg); (A) sham + G (175 mg/kg).
level occurred despite similar plasma gentamicin half-lives in
the two groups (IS+G: 42.2 7.5 vs. Sham+G: 41.2 2.1 mm;
N = 5). In addition, there was no difference between these
groups in the calculated peak plasma gentamicin level at time
zero (IS+G: 120.7 7.5 vs. Sham+G: 118.1 3.8 ig/g wet wt).
These data suggest that prior ischemia increases cortical gen-
tamicin levels by increased cellular uptake of filtered gentami-
cm. To determine if the elevated cortical gentamicin levels
accounted for or played an important role in the renal impair-
ment a third group of uninephrectomized sham operated rats
was treated with a higher dose (175 mg/kg) of gentamicin.
Cortical gentamicin levels in these rats (1443 148) were not
different from IS +G (100 mg/kg) treated rats (Table 1). How-
ever, the 24-hour plasma creatinine in these animals (0.9 0.1)
was significantly less than the IS+G (100 mg/kg) group (1.1
0.2; P < 0.05) and not different from the Sham+G (100 mg/kg)
group (0.8 0.1; NS, Table 1).
To further evaluate the dissociation between cortical genta-
micin levels and renal function, we analyzed the 24-hour
cortical gentamicin levels as a function of the 24 hour plasma
creatinine. Figure 3 demonstrates there was no correlation
between the 24 hour plasma creatinine and the cortical genta-
micin level for either the entire group (r = 0.34; P > 0.1) or the
IS+G (100 mg/kg) group (Figure 3 inset; P> 0.05), suggesting
that tissue gentamicin levels by themselves are not a major
determinate of nephrotoxicity in this model.
Discussion
In these studies we have shown that mild ischemia occurring
four hours prior to gentamicin administration both accelerates
and enhances gentamicin nephrotoxicity. Gentamicin or isch-
emia alone produced little renal injury (Figs. 1 and 2) whereas
the combination resulted in significant renal injury and in-
creased mortality. This was true despite the fact that cellular
morphology, the clearance of inulin and the fractional excretion
of Nat, following 15 minutes of ischemia and four hours of
recovery had normalized prior to gentamicin administration.
While prior ischemia resulted in higher cortical gentamicin
levels, presumably via increased cellular uptake of gentamicin,
this finding alone did not account for the enhanced toxicity. A
higher dose of gentamicin given to sham operated animals pro-
duced a cortical antibiotic level identical to the IS+G group, but
was not accompanied by increased nephrotoxici. This finding is
in agreement with previously published work [2, 7, 10, 18]. Zager
and Prior [2] reported that endotoxemia enhanced gentamicin
toxicity. While cortical gentamicin levels were higher in the
endotoxin plus gentamicin treated rats compared to gentamicin
treatment alone, similarly high tissue gentamicin levels, achieved
by larger doses of gentamicin, failed to produce the same toxicity.
In animal models, polyaspartic acid appeared to protect from
gentamicin toxicity despite high cortical antibiotic levels [18].
Additionally, the protective effect of oral calcium loading was
S 1/S2 degree
Treatment Absent ÷
of injury S3 degree of injury
+ + Total Absent + + + Total
Sham surgery 5 0 0 0/5 5 0 0 0/5
15 Minutes ischemia 5 0 0 0/5 5 0 0 0/5
Sham + G 100 mg/kg 8 0 0 0/8 7 1 0 1/8
Sham + G 175 mg/kg 4 1 0 1/5 4 1 0 1/5
Is + G 100 mg/kg 6 1 1 2/8 1 5 2 7/8
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achieved despite similar peak cortical gentamicin levels [8]. Taken
together, these studies suggest that the intracellular handling of
gentamicin is more important than the tissue level per se in
determining nephrotoxicity.
The site of injury in the ischemia plus gentamicin group was
unusual. Gentamicin toxicity primarily affects the Si and S2
segments of the proximal tubule [10, 19—21]. In fact, Wedeen et
al [22] have suggested that gentamicin may not be taken up by
the S3 segment in control rats. In the present study the major
site of gentamicin toxicity following mild ischemia, which alone
did not produce any significant injury at 24 hours, was the S3
segment. This finding suggests that prior ischemia greatly
increases the susceptibility of the S3 segment to gentamicin
injury. Zager [10] showed that gentamicin, in the presence of
concurrent ischemia (via hypoperfusion), also resulted in dam-
age to the S3 segment of the proximal tubule. This occurred
despite normal renal perfusion and could not be explained by
altered cortical ATP levels or lipid peroxidation. Because the
injuries were concurrent, he concluded that gentamicin could
precipitate hypoperfusion-induced renal failure. While we can-
not totally exclude the possibility that gentamicin adversely
effected renal hemodynamics, the normal inulin clearances,
performed immediately following the intravenous injection of
gentamicin into four hour post-ischemic rats, provides strong
evidence against it. Our data, therefore, suggest that mild
ischemia predisposes the S3 segment to acute gentamicin tox-
icity. This increased susceptibility of the S3 segment to genta-
micin injury following recovery from ischemia could occur via
increased gentamicin uptake by S3 cells and/or abnormal intra-
cellular processing of gentamicin following endocytosis. Since
the S3 segment is particularly sensitive to ischemic injury [23],
increased surface membrane reprocessing could facilitate the
uptake of gentamicin which is known to bind to acidic phos-
pholipids, particularly phosphatidylinositol, on the surface
membrane [24]. In support of this theory, previous work from
our laboratory has shown that ischemia results in the loss of
surface membrane polarity which leads to an abnormally high
phosphatidylinositol content of the apical membrane [11, 12].
The fact that a high dose of gentamicin (175 mg/kg) produced
the same cortical gentamicin levels as ischemia plus gentamicin
(100 mg/kg), without the morphologic injury, suggests that
increased cellular uptake may not be the sole enhancing mech-
anism. However, since the S3 segment makes up only a small
percentage of the renal cortex and since we did not measure
gentamicin levels in individual tubule segments we cannot
exclude the possibility that prior ischemia resulted in enhanced
S3 accumulation of gentamicin.
In summary, we have shown that mild renal ischemia greatly
enhanced gentamicin nephrotoxicity. While prior ischemia did
result in increased cortical gentamicin levels, this fact alone
could not account for the enhanced toxicity. The predominate
site of injury was the S3 segment of the proximal tubule. While
it is difficult to extrapolate from animal studies to clinical
medicine, our data suggest that clinically unrecognized tran-
sient renal ischemia may greatly predispose patients to rapidly
occurring and severe gentamicin induced nephrotoxicity. Acute
renal failure is common in critically ill patients who are also at
high risk for ischemic renal injury from hypotension and sepsis.
When ARF occurs in this patient population its cause is
generally considered to be multifactorial. This study suggests
that the interaction of very mild renal ischemia and subsequent
gentamicin administration may play an important role in the
high incidence of ARF seen in critically ill patients [25]. The
advisability of using gentamicin or other aminoglycoside anti-
biotics in this "high risk" patient population, now that newer
less nephrotoxic antibiotics are available, must therefore, be
questioned.
Acknowledgments
These studies were supported by the Veterans Administration Re-
search Service. Dr. Bruce A. Molitoris is a Veterans Administration
Clinical Investigator award recipient. Dr. Shanley was supported by a
Research Starter Grant from the Pharmaceutical Manufacturers Asso-
ciation Foundation, Washington, D.C. We thank Priscilla Mendez and
Alison Geerdes for secretarial and technical support, respectively.
Reprint requests to Bruce A. Molitoris, M.D., V.A. Medical Center,
1055 Cler,nont Street, Denver, Colorado 80220, USA.
References
1. HUME5 HD: Aminoglycoside nephrotoxicity, Kidney mt 33:900—
911, 1988
2. ZAGER RA, PRIOR RB: Gentamicin and gram-negative bacteremia:
A synergism for the development of experimental nephrotoxic
acute renal failure. J Clin Invest 78:196—204, 1986
3. RANKIN U, KROUS H, FRYER AW, WHANG R: Enhancement of
gentamicin nephrotoxicity by magnesium depletion in the rat.
Miner Electrol Metab 10:299—203, 1984
4. CRONIN RE, INMAN L, SPINDLER M: Effect of thyroid hormone on
rat proximal tubular lysosomal volume after gentamicin. (abstract)
Kidneymt 33:356, 1988
5. RA, VERPOOTEN GA. DE BROE ME: The effect of
dosing strategy on kidney cortical accumulation of aminoglycosides
in rats. Am J Kidney Dis 8:297—303, 1986
6. WILLIAMS PD, BENNETT DB, GLEASON CR, HOTTENDORF OH:
Correlation between renal membrane binding and nephrotoxicity of
aminoglycosides. Antimicrob Agents Chemother 31:570—574, 1987
7. BENNETT WM, PULLIAM JP, PORTER GA, HOUGHTON DC: Modi-
fication of experimental gentamicin nephrotoxicity by selective
parathyroidectomy. Am J Physiol 249:F832—F835, 1985
8. HUME5 DH, SASTRASINH M, WEINBERG JM: Calcium is a compet-
itive inhibitor of gentamicin-renal membrane binding interactions
and dietary calcium supplementation protects against gentamicin
nephrotoxicity. J Clin Invest 73:134—147, 1984
9. ZAGER RA, SHARMA HM, JOHANNE5 GA: Gentamicin increases
renal susceptibility to an acute ischemic insult. J Lab Clin Med
101:670—678, 1983
10. ZAGER RA: Gentamicin nephrotoxicity in the setting of acute renal
hypoperfusion. Am J Physiol 254:F574—F581, 1988
11. M0LIT0RI5 BA, H0ILIEN CA, DAI-IL R, AHNEN DJ, WILSON PD,
KIM J: Characterization of ischemia-induced loss of epithelial
polarity. J Membr Biol 106:233—242, 1988
12. MOLITORIS BA, WILSON PD, SCHRIER RW, SIMON FR: Ischemia
induces partial loss of surface membrane polarity and accumulation
of putative calcium ionophores. J Cliii Invest 76:2097—2105, 1985
13. ANDERSON Ri, TAHER MS. CRONIN RE, MCDONALD KM,
SCHRIER RW: Effects of x-adrenergic blockade and inhibitors of
angiotensin II and prostaglandin on renal autoregulation. AmI
Physiol 229:731—736, 1975
14. GIULLIANO RA, VERPOOTEN GA, POLLET DE, VERBIST L,
SCHARPE SL, DE BROE MC: Improved procedure for extracting
aminoglycosides from renal cortical tissue. Antimicro Agents Che-
mother 25:783—784, 1984
15. DONOHOE JF, VENKATACHALAM MA, BERNARD DA, LEVINSKY N:
Tubular leakage and obstruction after renal ischemia: Structural-
functional correlations. Kidney mt 13:208—222, 1978
464 Spiegel et a!: Gentamicin toxicity in the S3 segment
16. GLAUMANN B, GLAUMANN H, BEREZESKY 1K, TRUMP BF: Studies
of cellular recovery from injury ultrastructural studies on the
recovery of the pars convoluta of the proximal tubule of the rat
kidney from temporary ischemia. Virchows Arch B Cell Pathol
24: 1—18, 1977
17. GLAUMANN B, GLAUMANN H, TRUMP BF: Studies of cellular
recovery from injury ultrastructural studies on the recovery of the
pars recta of the proximal tubule (P3 Segment) of the rat kidney
from temporary ischemia. Virchows Arch B Cell Pathology 25:281—
308, )77
18. BENNETT WM, WooD CA, KOHLHEPP Si, KORNEN PW, HOUGH-
TON DC, GILBERT DN: Experimental gentamicin (0) nephrotoxic-
ity can be prevented by polyaspartic acid (PAA). (abstract) Kidney
mt 33:353, 1988
19. HOUGHTON DC, HARTNETF M, CAMPBELL-BOSWELL M, PORTER
G, BENNETT W: A light and electron microscopic analysis of
gentamicin nephrotoxicity in rats. Am J Pathol 82:589—612, 1976
20. MORIN JP, VIO-rrE G, VANDERWALLE A, VAN HOOF F, TULKENS
P, FILLASTRE JP: Gentamicin-induced nephrotoxicity: A cell biol-
ogy approach. Kidney mt 18:583—590, 1988
21. SILVERBLATT FJ, KUEHN C: Autoradiography of gentamicin up-
take by the rat proximal tubule cell. Kidney mt 15:335—345, 1979
22. WEDEEN RP, BATUMAN V, CHEEKS C, MARQUET E, SOBEL H:
Transport of gentamicin in rat proximal tubule. Lab Invest 48:212—
223, 1983
23. SHANLEY PF, ROSEN MD, BREZIS M, SILVA P, EPSTEIN FH,
ROSEN S: Topography of focal proximal tubular necrosis after
ischemia with reflow in the rat kidney. Am J Pathol 122:462—468,
1986
24. SASTRASINH M, KNAUSS TC, WEINBERG JM, HUMES HD: Identi-
fication of the aminoglycoside binding site in rat renal brush border
membranes. J Pharmacol Exp Ther 222:350—358, 1982
25. SMITH CR, AMBINDER R, LIPSKY ii, PETTY BG, ISRAEL E, LEVITT
R, MELLITS ED, Rocco L, LONGSTRETH J, LIETMAN PS: Cefotax-
ime compared with nafcillin plus tobramycin for serious bacterial
infections a randomized, double-blind trial. Anna! Intern Med
101:469—477, 1984
